Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells.

Molecules (Basel, Switzerland) - 31 May 2023

Shechter Sharon, Ya'ar Bar Sapir, Khattib Hamdan, Gage Matthew J, Avni Dorit

Abstract excerpt

The vulnerabilities of cancer cells constitute a promising strategy for drug therapeutics. This paper integrates proteomics, bioinformatics, and cell genotype together with in vitro cell proliferation assays to identify key biological processes and potential novel kinases that could account, at least in part, for the clinical differences observed in colorectal cancer (CRC) patients. This study started by focusing...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Colorectal Neoplasms
Share to Mutation
Share to Proto-Oncogene Proteins p21(ras)

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Signal Transduction

Share to Tumor Suppressor Protein p53

Source

Open in PubMed Open full text

Identifiers

PMID: 37298928
DOI: 10.3390/molecules28114452
PMCID: PMC10254355

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Riok1, A Novel Potential Target in MSI-High p53 Mutant Colorectal Cancer Cells.PMID 37298928Read ↗

Integrated multi-omics characterization of KRAS mutant colorectal cancer.Semantic proximity Read ↗

Molecular and functional profiling unravels targetable vulnerabilities in colorectal cancerSemantic proximity Read ↗

An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapySemantic proximity Read ↗

Pancancer Fine-Mapping of Mutational Intolerance Identifies CHEK1 as an Immunosuppressive Driver in Lung Adenocarcinoma.Semantic proximity Read ↗

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targetsSemantic proximity Read ↗

Gene Expression Patterns in Mismatch Repair-Deficient Colorectal Cancers Highlight the Potential Therapeutic Role of Inhibitors of the Phosphatidylinositol 3-Kinase-AKT-Mammalian Target of Rapamycin PathwaySemantic proximity Read ↗

Sensitivities and Dependencies of BRAF Mutant Colorectal Cancer Cell Lines with or without PIK3CA Mutations for Discovery of Vulnerabilities with Therapeutic Potential.Semantic proximity Read ↗

Mutations in Classical Signaling Pathways and Their Functional Impact in Microsatellite Instability High Colorectal Cancer.Semantic proximity Read ↗

Integrated Molecular Characterisation of the MAPK Pathways in Human CancersSemantic proximity Read ↗

Integrated molecular characterisation of the MAPK pathways in human cancers reveals pharmacologically vulnerable mutations and gene dependencies.Semantic proximity Read ↗

Cell line models for drug discovery in PIK3CA-mutated colorectal cancers.Semantic proximity Read ↗

TP53 missense–specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.